This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Eagle Pharmaceuticals, Inc., doing business as Eagle Pharmaceuticals. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $5,080.62 and an ultimate completion date of November 12, 2024. The contract is for the supply of Ryanodex, a 250mg injectable medication used to treat and prevent malignant hyperthermia in high-risk patients.
Eagle Pharmaceuticals is a for-profit pharmaceutical manufacturer specializing in the production of critical pharmaceutical products. The company holds a significant Federal Supply Schedule (FSS) contract with the Department of Veterans Affairs (VA) Veterans Health Administration, valued at $30,890,560 and effective from February 2024 through January 2029, which enables the VA and DLA to efficiently procure the company's pharmaceutical products, including Ryanodex. This contract supports medical readiness initiatives for the Department of Defense and the delivery of essential medications to VA medical facilities.
Generated 2/5/25, 9:12 AM